Market Tracker

05/25 5:15pm ET

Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.23
Delayed Data
As of May 25
 +0.07 / +3.24%
Today’s Change
1.42
Today|||52-Week Range
4.37
+10.40%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close2.16
Today’s open2.18
Day’s range2.15 - 2.25
Volume282,664
Average volume (3 months)394,573
Market cap$67.9M
Data as of 8:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-130.00%
Earnings growth (this year)+29.35%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.05

Competitors

 Today’s
change
Today’s
% change
AGLEAeglea Bio Therapeut...+0.90+9.26%
NBYNovaBay Pharmaceutic...+0.02+0.79%
--Innovative Pharmaceu...0.000.00%
FLKSFlex Pharma Inc+0.03+0.78%
Data as of 8:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$25.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
President &
Chief Financial Officer
Douglas J. Swirsky
Corporate headquarters
Rockville, Maryland

Forecasts